---
figid: PMC7456566__nihms-1611034-f0003
figlink: pmc/articles/PMC7456566/figure/F3/
number: F3
caption: Key processes of apoptosis, cell proliferation, cellular differentiation,
  and epigenetic homeostasis are deregulated by mutation or gene copy-number and/or
  gene expression alterations in fusion negative (FN) or fusion positive (FP) rhabdomyosarcoma
  (RMS). In FP RMS, chromosomal translocations result in PAX3–FOXO1 or PAX7–FOXO1
  fusion genes. The aberrant PAX3–FOXO1 fusion protein can synergize with loss of
  p16 or p53 functionality that is associated with CDKN2A gene loss and/or promoter
  methylation and TP53 mutation. The stability and subcellular localization of the
  PAX3–FOXO1 protein is dependent on phosphorylation of specific sites and it works
  in a complex that can include BRD4. The PAX3-FOXO1 containing complex acts as pioneer
  factor and drives expression of other transcription factors such as MYCN and MYOD1
  via super-enhancers that lead to reprogramming of the transcriptional and epigenetic
  landscape of tumors. The genes encoding MYCN and MYOD1 transcription factors may
  themselves be genetically amplified or mutated, likely contributing to RMS formation
  or progression in a subset of cases, respectively. The fusion protein also drives
  expression of specific receptor tyrosine kinases (RTKs). Overexpression and activating
  mutations of genes encoding the same RTKs, and mutation of genes encoding downstream
  signaling components, are seen in FN RMS. Together this leads to frequent activation
  of PI3K and RAS pathway signaling in FP and FN RMS, which likely contribute to disease
  pathogenesis by altering cell proliferation, apoptosis, and other metabolic pathways
  in ways that are not yet precisely defined. Next-generation DNA sequencing and other
  molecular genetics tools have demonstrated deleterious mutations in genes encoding
  certain proteins involved in RMS pathogenesis (*). Exactly how these pathways driven
  RMS pathogenesis is not clear.
pmcid: PMC7456566
papertitle: Rhabdomyosarcoma.
reftext: Stephen X. Skapek, et al. Nat Rev Dis Primers. ;5(1):1-1.
pmc_ranked_result_index: '50786'
pathway_score: 0.962836
filename: nihms-1611034-f0003.jpg
figtitle: Rhabdomyosarcoma
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7456566__nihms-1611034-f0003.html
  '@type': Dataset
  description: Key processes of apoptosis, cell proliferation, cellular differentiation,
    and epigenetic homeostasis are deregulated by mutation or gene copy-number and/or
    gene expression alterations in fusion negative (FN) or fusion positive (FP) rhabdomyosarcoma
    (RMS). In FP RMS, chromosomal translocations result in PAX3–FOXO1 or PAX7–FOXO1
    fusion genes. The aberrant PAX3–FOXO1 fusion protein can synergize with loss of
    p16 or p53 functionality that is associated with CDKN2A gene loss and/or promoter
    methylation and TP53 mutation. The stability and subcellular localization of the
    PAX3–FOXO1 protein is dependent on phosphorylation of specific sites and it works
    in a complex that can include BRD4. The PAX3-FOXO1 containing complex acts as
    pioneer factor and drives expression of other transcription factors such as MYCN
    and MYOD1 via super-enhancers that lead to reprogramming of the transcriptional
    and epigenetic landscape of tumors. The genes encoding MYCN and MYOD1 transcription
    factors may themselves be genetically amplified or mutated, likely contributing
    to RMS formation or progression in a subset of cases, respectively. The fusion
    protein also drives expression of specific receptor tyrosine kinases (RTKs). Overexpression
    and activating mutations of genes encoding the same RTKs, and mutation of genes
    encoding downstream signaling components, are seen in FN RMS. Together this leads
    to frequent activation of PI3K and RAS pathway signaling in FP and FN RMS, which
    likely contribute to disease pathogenesis by altering cell proliferation, apoptosis,
    and other metabolic pathways in ways that are not yet precisely defined. Next-generation
    DNA sequencing and other molecular genetics tools have demonstrated deleterious
    mutations in genes encoding certain proteins involved in RMS pathogenesis (*).
    Exactly how these pathways driven RMS pathogenesis is not clear.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGFR4
  - PDGFA
  - MET
  - IGF1R
  - PDGFB
  - ERBB2
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - HRAS
  - KRAS
  - NRAS
  - AKT2
  - AKT3
  - AKT1
  - ARAF
  - BRAF
  - RAF1
  - MTOR
  - MAP2K1
  - MAP2K2
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - MAK
  - CDKN2A
  - PLK1
  - CCND1
  - MDM2
  - MYCN
  - CDK4
  - E2F3
  - E2F8
  - E2F1
  - E2F2
  - E2F4
  - E2F5
  - E2F6
  - E2F7
genes:
- word: FGFR4*
  symbol: FGFR4
  source: hgnc_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: PDGFa
  symbol: PDGFA
  source: hgnc_symbol
  hgnc_symbol: PDGFA
  entrez: '5154'
- word: МЕT
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: 'IGF1R:'
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: PDGFB
  symbol: PDGFB
  source: hgnc_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
- word: ERBB2
  symbol: ERBB2
  source: hgnc_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: PI3K*
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K*
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K*
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K*
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K*
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K*
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K*
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K*
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAS*
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS*
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS*
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: CDKN2A*
  symbol: CDKN2A
  source: hgnc_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: PLK1
  symbol: PLK1
  source: hgnc_symbol
  hgnc_symbol: PLK1
  entrez: '5347'
- word: CCND1
  symbol: CCND1
  source: hgnc_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: MDM2*
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: MYCN
  symbol: MYCN
  source: hgnc_symbol
  hgnc_symbol: MYCN
  entrez: '4613'
- word: CDK4*
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
chemicals: []
diseases: []
figid_alias: PMC7456566__F3
redirect_from: /figures/PMC7456566__F3
figtype: Figure
---
